Annual Net Income
-$22.27 M
-$4.68 M-26.59%
31 December 2023
Summary:
Gain Therapeutics annual net profit is currently -$22.27 million, with the most recent change of -$4.68 million (-26.59%) on 31 December 2023. During the last 3 years, it has fallen by -$8.38 million (-60.31%). GANX annual net income is now -1914.25% below its all-time high of -$1.11 million, reached on 31 December 2018.GANX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$4.49 M
+$3.66 M+44.91%
30 September 2024
Summary:
Gain Therapeutics quarterly net profit is currently -$4.49 million, with the most recent change of +$3.66 million (+44.91%) on 30 September 2024. Over the past year, it has increased by +$238.30 thousand (+5.04%). GANX quarterly net income is now -725.49% below its all-time high of -$543.40 thousand, reached on 30 June 2020.GANX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$21.37 M
+$232.60 K+1.08%
30 September 2024
Summary:
Gain Therapeutics TTM net profit is currently -$21.37 million, with the most recent change of +$232.60 thousand (+1.08%) on 30 September 2024. Over the past year, it has increased by +$900.60 thousand (+4.04%). GANX TTM net income is now -3556.85% below its all-time high of -$584.30 thousand, reached on 31 March 2020.GANX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GANX Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | +5.0% | +4.0% |
3 y3 years | -60.3% | -39.3% | -53.8% |
5 y5 years | -915.2% | - | - |
GANX Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -60.3% | at low | -39.3% | +44.9% | -53.8% | +4.0% |
5 y | 5 years | -915.2% | at low | -725.5% | +44.9% | -3556.8% | +4.0% |
alltime | all time | -1914.3% | at low | -725.5% | +44.9% | -3556.8% | +4.0% |
Gain Therapeutics Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$4.49 M(-44.9%) | -$21.37 M(-1.1%) |
June 2024 | - | -$8.14 M(+102.9%) | -$21.60 M(+2.2%) |
Mar 2024 | - | -$4.01 M(-15.0%) | -$21.14 M(-5.0%) |
Dec 2023 | -$22.27 M(+26.6%) | -$4.72 M(+0.1%) | -$22.27 M(+0.2%) |
Sept 2023 | - | -$4.72 M(-38.6%) | -$22.22 M(+0.7%) |
June 2023 | - | -$7.69 M(+49.7%) | -$22.06 M(+13.4%) |
Mar 2023 | - | -$5.14 M(+9.9%) | -$19.46 M(+10.6%) |
Dec 2022 | -$17.59 M(+26.6%) | -$4.67 M(+2.6%) | -$17.59 M(+9.0%) |
Sept 2022 | - | -$4.56 M(-10.4%) | -$16.14 M(-0.6%) |
June 2022 | - | -$5.09 M(+55.4%) | -$16.24 M(+10.4%) |
Mar 2022 | - | -$3.27 M | -$14.71 M |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$13.89 M(+288.3%) | - | - |
Dec 2021 | - | -$3.22 M(-31.0%) | -$13.89 M(+12.7%) |
Sept 2021 | - | -$4.66 M(+31.1%) | -$12.33 M(+45.7%) |
June 2021 | - | -$3.56 M(+45.1%) | -$8.46 M(+55.4%) |
Mar 2021 | - | -$2.45 M(+48.0%) | -$5.44 M(+52.2%) |
Dec 2020 | -$3.58 M(+63.1%) | - | - |
Dec 2020 | - | -$1.66 M(+108.4%) | -$3.58 M(+86.1%) |
Sept 2020 | - | -$794.40 K(+46.2%) | -$1.92 M(+70.4%) |
June 2020 | - | -$543.40 K(-7.0%) | -$1.13 M(+93.0%) |
Mar 2020 | - | -$584.30 K | -$584.30 K |
Dec 2019 | -$2.19 M(+98.4%) | - | - |
Dec 2018 | -$1.11 M | - | - |
FAQ
- What is Gain Therapeutics annual net profit?
- What is the all time high annual net income for Gain Therapeutics?
- What is Gain Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Gain Therapeutics?
- What is Gain Therapeutics quarterly net income year-on-year change?
- What is Gain Therapeutics TTM net profit?
- What is the all time high TTM net income for Gain Therapeutics?
- What is Gain Therapeutics TTM net income year-on-year change?
What is Gain Therapeutics annual net profit?
The current annual net income of GANX is -$22.27 M
What is the all time high annual net income for Gain Therapeutics?
Gain Therapeutics all-time high annual net profit is -$1.11 M
What is Gain Therapeutics quarterly net profit?
The current quarterly net income of GANX is -$4.49 M
What is the all time high quarterly net income for Gain Therapeutics?
Gain Therapeutics all-time high quarterly net profit is -$543.40 K
What is Gain Therapeutics quarterly net income year-on-year change?
Over the past year, GANX quarterly net profit has changed by +$238.30 K (+5.04%)
What is Gain Therapeutics TTM net profit?
The current TTM net income of GANX is -$21.37 M
What is the all time high TTM net income for Gain Therapeutics?
Gain Therapeutics all-time high TTM net profit is -$584.30 K
What is Gain Therapeutics TTM net income year-on-year change?
Over the past year, GANX TTM net profit has changed by +$900.60 K (+4.04%)